The Faculty of Pain Medicine says there needs to be more clinical evidence about the efficacy of medicinal cannabis before use as a treatment for chronic, non-cancer pain.

Changes to item mapping in the MBS affecting both pain medicine and anaesthesia will come into effect on 1 March 2022.

Your monthly digest of professional document developments.

The eagerly anticipated fifth edition is now available as a free download.

The faculty has now completed a comprehensive review of the training program curriculum to ensure its accuracy and quality.

This new resource for patients provides a summary of our position on prescribing medicinal cannabis for people with chronic non-cancer pain.

FPM dean, Associate Professor Mick Vagg, is calling on faculty fellows to condemn the Australian Government's decision to cut $40 million from desperately needed services for people living with chronic pain after it rejected key recommendations from a national taskforce.

The board has approved a new position statement on the use of ketamine in the management of chronic non-cancer pain

The college has provided a 2022 election priorities statement to the major political parties.

A digest of college news coverage for May/June 2022